Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W.

Epilepsia. 2018 Jan;59(1):37-66. doi: 10.1111/epi.13965. Epub 2017 Dec 15. Review.

PMID:
29247482
2.

Epilepsy and astrocyte energy metabolism.

Boison D, Steinhäuser C.

Glia. 2018 Jun;66(6):1235-1243. doi: 10.1002/glia.23247. Epub 2017 Oct 17. Review.

PMID:
29044647
3.

Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation.

Xu Y, Wang Y, Yan S, Yang Q, Zhou Y, Zeng X, Liu Z, An X, Toque HA, Dong Z, Jiang X, Fulton DJ, Weintraub NL, Li Q, Bagi Z, Hong M, Boison D, Wu C, Huo Y.

Nat Commun. 2017 Oct 16;8(1):943. doi: 10.1038/s41467-017-00986-7.

4.

Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle.

Clasadonte J, Scemes E, Wang Z, Boison D, Haydon PG.

Neuron. 2017 Sep 13;95(6):1365-1380.e5. doi: 10.1016/j.neuron.2017.08.022. Epub 2017 Aug 31.

PMID:
28867552
5.

Intracellular adenosine regulates epigenetic programming in endothelial cells to promote angiogenesis.

Xu Y, Wang Y, Yan S, Zhou Y, Yang Q, Pan Y, Zeng X, An X, Liu Z, Wang L, Xu J, Cao Y, Fulton DJ, Weintraub NL, Bagi Z, Hoda MN, Wang X, Li Q, Hong M, Jiang X, Boison D, Weber C, Wu C, Huo Y.

EMBO Mol Med. 2017 Sep;9(9):1263-1278. doi: 10.15252/emmm.201607066.

6.

Corrigendum: Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction.

Acharya MM, Baulch JE, Lusardi TA, Allen BD, Chmielewski NN, Baddour AAD, Limoli CL, Boison D.

Front Mol Neurosci. 2017 Jul 10;10:218. doi: 10.3389/fnmol.2017.00218. eCollection 2017.

7.

Engineering Human Mesenchymal Stem Cells to Release Adenosine Using miRNA Technology.

Ren G, Boison D.

Methods Mol Biol. 2017;1622:225-239. doi: 10.1007/978-1-4939-7108-4_16.

PMID:
28674812
8.

Editorial: Metabolic Control of Brain Homeostasis.

Boison D, Meier JC, Masino SA.

Front Mol Neurosci. 2017 Jun 9;10:184. doi: 10.3389/fnmol.2017.00184. eCollection 2017. No abstract available.

9.

New insights into the mechanisms of the ketogenic diet.

Boison D.

Curr Opin Neurol. 2017 Apr;30(2):187-192. doi: 10.1097/WCO.0000000000000432. Review.

10.

Adenosine receptors regulate susceptibility to noise-induced neural injury in the mouse cochlea and hearing loss.

Vlajkovic SM, Ambepitiya K, Barclay M, Boison D, Housley GD, Thorne PR.

Hear Res. 2017 Mar;345:43-51. doi: 10.1016/j.heares.2016.12.015. Epub 2016 Dec 26.

PMID:
28034618
11.

Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.

Sandau US, Colino-Oliveira M, Jones A, Saleumvong B, Coffman SQ, Liu L, Miranda-Lourenço C, Palminha C, Batalha VL, Xu Y, Huo Y, Diógenes MJ, Sebastião AM, Boison D.

J Neurosci. 2016 Nov 30;36(48):12117-12128.

12.

Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation.

Kiese K, Jablonski J, Boison D, Kobow K.

Front Mol Neurosci. 2016 Oct 20;9:99. eCollection 2016.

13.

Mouse Oocytes Acquire Mechanisms That Permit Independent Cell Volume Regulation at the End of Oogenesis.

Richard S, Tartia AP, Boison D, Baltz JM.

J Cell Physiol. 2017 Sep;232(9):2436-2446. doi: 10.1002/jcp.25581. Epub 2017 Mar 27.

PMID:
27589375
14.

A mitochondria targeting Mn nanoassembly of BODIPY for LDH-A, mitochondria modulated therapy and bimodal imaging of cancer.

Boison D, Lu WL, Xu QM, Yang H, Huang T, Chen QY, Gao J, Zhao Y.

Colloids Surf B Biointerfaces. 2016 Nov 1;147:387-396. doi: 10.1016/j.colsurfb.2016.08.024. Epub 2016 Aug 18.

PMID:
27559997
15.

South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.

Toti KS, Osborne D, Ciancetta A, Boison D, Jacobson KA.

J Med Chem. 2016 Jul 28;59(14):6860-77. doi: 10.1021/acs.jmedchem.6b00689. Epub 2016 Jul 13.

16.

Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction.

Acharya MM, Baulch JE, Lusardi TA, Allen BD, Chmielewski NN, Baddour AA, Limoli CL, Boison D.

Front Mol Neurosci. 2016 Jun 3;9:42. doi: 10.3389/fnmol.2016.00042. eCollection 2016. Erratum in: Front Mol Neurosci. 2017 Jul 10;10 :218.

17.

The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine.

Boison D.

Front Mol Neurosci. 2016 Apr 13;9:26. doi: 10.3389/fnmol.2016.00026. eCollection 2016. Review.

18.

Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.

Lu NN, Weng ZY, Chen QY, Boison D, Xiao XX, Gao J.

Spectrochim Acta A Mol Biomol Spectrosc. 2016 Aug 5;165:21-5. doi: 10.1016/j.saa.2016.04.010. Epub 2016 Apr 13.

PMID:
27104676
19.

A Mn(II) complex of boradiazaindacene (BODIPY) loaded graphene oxide as both LED light and H2O2 enhanced anticancer agent.

Xu XL, Shao J, Chen QY, Li CH, Kong MY, Fang F, Ji L, Boison D, Huang T, Gao J, Feng CJ.

J Inorg Biochem. 2016 Jun;159:1-6. doi: 10.1016/j.jinorgbio.2016.02.007. Epub 2016 Feb 13.

PMID:
26901626
20.

Purines: forgotten mediators in traumatic brain injury.

Jackson EK, Boison D, Schwarzschild MA, Kochanek PM.

J Neurochem. 2016 Apr;137(2):142-53. doi: 10.1111/jnc.13551. Epub 2016 Feb 25. Review.

21.

From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy.

Richerson GB, Boison D, Faingold CL, Ryvlin P.

Epilepsia. 2016 Jan;57 Suppl 1:35-45. doi: 10.1111/epi.13236. Review.

22.

microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus.

Jimenez-Mateos EM, Arribas-Blazquez M, Sanz-Rodriguez A, Concannon C, Olivos-Ore LA, Reschke CR, Mooney CM, Mooney C, Lugara E, Morgan J, Langa E, Jimenez-Pacheco A, Silva LF, Mesuret G, Boison D, Miras-Portugal MT, Letavic M, Artalejo AR, Bhattacharya A, Diaz-Hernandez M, Henshall DC, Engel T.

Sci Rep. 2015 Dec 3;5:17486. doi: 10.1038/srep17486.

23.

Inhibition of Adenosine Kinase Attenuates Acute Lung Injury.

Köhler D, Streienberger A, Morote-García JC, Granja TF, Schneider M, Straub A, Boison D, Rosenberger P.

Crit Care Med. 2016 Apr;44(4):e181-9. doi: 10.1097/CCM.0000000000001370.

24.

Adenosinergic signaling in epilepsy.

Boison D.

Neuropharmacology. 2016 May;104:131-9. doi: 10.1016/j.neuropharm.2015.08.046. Epub 2015 Sep 1. Review.

25.

Glycine transporter 1 is a target for the treatment of epilepsy.

Shen HY, van Vliet EA, Bright KA, Hanthorn M, Lytle NK, Gorter J, Aronica E, Boison D.

Neuropharmacology. 2015 Dec;99:554-65. doi: 10.1016/j.neuropharm.2015.08.031. Epub 2015 Aug 21.

26.

Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.

Lusardi TA, Akula KK, Coffman SQ, Ruskin DN, Masino SA, Boison D.

Neuropharmacology. 2015 Dec;99:500-9. doi: 10.1016/j.neuropharm.2015.08.007. Epub 2015 Aug 6.

27.

Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development.

Diamond ML, Ritter AC, Jackson EK, Conley YP, Kochanek PM, Boison D, Wagner AK.

Epilepsia. 2015 Aug;56(8):1198-206. doi: 10.1111/epi.13044. Epub 2015 Jun 4.

28.

Comorbidities in Neurology: Is adenosine the common link?

Boison D, Aronica E.

Neuropharmacology. 2015 Oct;97:18-34. doi: 10.1016/j.neuropharm.2015.04.031. Epub 2015 May 13. Review.

29.

Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.

Matos M, Shen HY, Augusto E, Wang Y, Wei CJ, Wang YT, Agostinho P, Boison D, Cunha RA, Chen JF.

Biol Psychiatry. 2015 Dec 1;78(11):763-74. doi: 10.1016/j.biopsych.2015.02.026. Epub 2015 Feb 27.

30.

Estimating cocoa bean parameters by FT-NIRS and chemometrics analysis.

Teye E, Huang X, Sam-Amoah LK, Takrama J, Boison D, Botchway F, Kumi F.

Food Chem. 2015 Jun 1;176:403-10. doi: 10.1016/j.foodchem.2014.12.042. Epub 2014 Dec 18.

PMID:
25624249
31.

Dravet in the dish: mechanisms of hyperexcitability.

Boison D.

Epilepsy Curr. 2014 Sep;14(5):279-80. doi: 10.5698/1535-7597-14.5.279. No abstract available.

32.

Deep brain stimulation in the dish: focus on mechanisms.

Boison D.

Epilepsy Curr. 2014 Jul;14(4):201-2. doi: 10.5698/1535-7597-14.4.201. No abstract available.

33.

Ketogenic diet sensitizes glucose control of hippocampal excitability.

Kawamura M Jr, Ruskin DN, Geiger JD, Boison D, Masino SA.

J Lipid Res. 2014 Nov;55(11):2254-60. doi: 10.1194/jlr.M046755. Epub 2014 Aug 28.

34.

When GABA Fails: Rundown on Chemokines.

Boison D.

Epilepsy Curr. 2014 May;14(3):155-7. doi: 10.5698/1535-7597-14.3.155. No abstract available.

35.

From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Flaten V, Laurent C, Coelho JE, Sandau U, Batalha VL, Burnouf S, Hamdane M, Humez S, Boison D, Lopes LV, Buée L, Blum D.

Biochem Soc Trans. 2014 Apr;42(2):587-92. doi: 10.1042/BST20130229. Review.

36.

The Concise Guide to PHARMACOLOGY 2013/14: overview.

Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators, Abul-Hasn N, Anderson CM, Anderson CM, Araiksinen MS, Arita M, Arthofer E, Barker EL, Barratt C, Barnes NM, Bathgate R, Beart PM, Belelli D, Bennett AJ, Birdsall NJ, Boison D, Bonner TI, Brailsford L, Bröer S, Brown P, Calo G, Carter WG, Catterall WA, Chan SL, Chao MV, Chiang N, Christopoulos A, Chun JJ, Cidlowski J, Clapham DE, Cockcroft S, Connor MA, Cox HM, Cuthbert A, Dautzenberg FM, Davenport AP, Dawson PA, Dent G, Dijksterhuis JP, Dollery CT, Dolphin AC, Donowitz M, Dubocovich ML, Eiden L, Eidne K, Evans BA, Fabbro D, Fahlke C, Farndale R, Fitzgerald GA, Fong TM, Fowler CJ, Fry JR, Funk CD, Futerman AH, Ganapathy V, Gaisnier B, Gershengorn MA, Goldin A, Goldman ID, Gundlach AL, Hagenbuch B, Hales TG, Hammond JR, Hamon M, Hancox JC, Hauger RL, Hay DL, Hobbs AJ, Hollenberg MD, Holliday ND, Hoyer D, Hynes NA, Inui KI, Ishii S, Jacobson KA, Jarvis GE, Jarvis MF, Jensen R, Jones CE, Jones RL, Kaibuchi K, Kanai Y, Kennedy C, Kerr ID, Khan AA, Klienz MJ, Kukkonen JP, Lapoint JY, Leurs R, Lingueglia E, Lippiat J, Lolait SJ, Lummis SC, Lynch JW, MacEwan D, Maguire JJ, Marshall IL, May JM, McArdle CA, McGrath JC, Michel MC, Millar NS, Miller LJ, Mitolo V, Monk PN, Moore PK, Moorhouse AJ, Mouillac B, Murphy PM, Neubig RR, Neumaier J, Niesler B, Obaidat A, Offermanns S, Ohlstein E, Panaro MA, Parsons S, Pwrtwee RG, Petersen J, Pin JP, Poyner DR, Prigent S, Prossnitz ER, Pyne NJ, Pyne S, Quigley JG, Ramachandran R, Richelson EL, Roberts RE, Roskoski R, Ross RA, Roth M, Rudnick G, Ryan RM, Said SI, Schild L, Sanger GJ, Scholich K, Schousboe A, Schulte G, Schulz S, Serhan CN, Sexton PM, Sibley DR, Siegel JM, Singh G, Sitsapesan R, Smart TG, Smith DM, Soga T, Stahl A, Stewart G, Stoddart LA, Summers RJ, Thorens B, Thwaites DT, Toll L, Traynor JR, Usdin TB, Vandenberg RJ, Villalon C, Vore M, Waldman SA, Ward DT, Willars GB, Wonnacott SJ, Wright E, Ye RD, Yonezawa A, Zimmermann M.

Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444.

37.

Chopping Out CHOP Chops the Fate of Neurons.

Boison D.

Epilepsy Curr. 2013 Sep;13(5):219-20. doi: 10.5698/1535-7597-13.5.219. No abstract available.

38.

Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation.

Shen HY, Canas PM, Garcia-Sanz P, Lan JQ, Boison D, Moratalla R, Cunha RA, Chen JF.

PLoS One. 2013 Nov 28;8(11):e80902. doi: 10.1371/journal.pone.0080902. eCollection 2013.

39.

Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice.

Shen HY, Sun H, Hanthorn MM, Zhi Z, Lan JQ, Poulsen DJ, Wang RK, Boison D.

J Neurosurg. 2014 Mar;120(3):628-38. doi: 10.3171/2013.10.JNS13918. Epub 2013 Nov 22.

40.

Role of adenosine in status epilepticus: a potential new target?

Boison D.

Epilepsia. 2013 Sep;54 Suppl 6:20-2. doi: 10.1111/epi.12268. Review.

41.

Homeostatic control of brain function - new approaches to understand epileptogenesis.

Boison D, Sandau US, Ruskin DN, Kawamura M Jr, Masino SA.

Front Cell Neurosci. 2013 Jul 16;7:109. doi: 10.3389/fncel.2013.00109. eCollection 2013.

42.

Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.

Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D.

J Clin Invest. 2013 Aug;123(8):3552-63. doi: 10.1172/JCI65636. Epub 2013 Jul 25.

43.

Glowing feet control the blood of seizures.

Boison D.

Epilepsy Curr. 2013 May;13(3):122-3. doi: 10.5698/1535-7511-13.3.122. No abstract available.

44.

Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain.

Wei CJ, Augusto E, Gomes CA, Singer P, Wang Y, Boison D, Cunha RA, Yee BK, Chen JF.

Biol Psychiatry. 2014 Jun 1;75(11):855-63. doi: 10.1016/j.biopsych.2013.05.003. Epub 2013 Jun 29.

45.

Ketogenic diet improves core symptoms of autism in BTBR mice.

Ruskin DN, Svedova J, Cote JL, Sandau U, Rho JM, Kawamura M Jr, Boison D, Masino SA.

PLoS One. 2013 Jun 5;8(6):e65021. doi: 10.1371/journal.pone.0065021. Print 2013.

46.

Adenosine kinase: exploitation for therapeutic gain.

Boison D.

Pharmacol Rev. 2013 Apr 16;65(3):906-43. doi: 10.1124/pr.112.006361. Print 2013 Jul. Review.

47.

Adenosine and seizure termination: endogenous mechanisms.

Boison D.

Epilepsy Curr. 2013 Jan;13(1):35-7. doi: 10.5698/1535-7511-13.1.35. No abstract available.

48.

Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Aronica E, Sandau US, Iyer A, Boison D.

Neurochem Int. 2013 Dec;63(7):688-95. doi: 10.1016/j.neuint.2013.01.028. Epub 2013 Feb 4. Review.

49.

Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning.

Singer P, Zhang C, Boison D, Yee BK.

Pharmacol Biochem Behav. 2013 Mar;104:80-9. doi: 10.1016/j.pbb.2012.12.012. Epub 2013 Jan 2.

50.

Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning.

Singer P, Wei CJ, Chen JF, Boison D, Yee BK.

Behav Brain Res. 2013 Apr 1;242:54-61. doi: 10.1016/j.bbr.2012.12.024. Epub 2012 Dec 28.

Supplemental Content

Loading ...
Support Center